• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Dr. Reddy's Laboratories Limited — Board Meeting, 22-07-2026: Outcome of Board Meeting

    22-07-2026 | 04:18 pm

    Dr. Reddy's Q1 consolidated revenue hit ₹8,070.5 Cr, with profit at ₹443.5 Cr. A ₹239.7 Cr charge for semaglutide API issues impacted margins. Despite this, core business delivered strong growth. Dr. Sridevi Khambhampaty is now Global Head of Biologics.

    No comments yet. Be the first to comment!

    All announcements from Dr. Reddy's Laboratories Limited